Abstract
The major function of platelets is to maintain the hemostatic integrity of the blood vessel and to stop bleeding after injury. Platelets show different responses that can be studied separately in vitro, but that are closely linked during hemostasis in vivo: adhesion and shape change, aggregation and secretion. Many diverse substances can activate platelets, and platelets are very sensitive to these agents and react within seconds of exposure to these stimuli. The most important physiological stimuli are von Willebrand factor and collagen, which mediate platelet adhesion; thrombin, which is generated by the coagulation system; prostaglandin endoperoxides, thromboxane, and ADP, which are released from activated platelets; platelet-activating factor, which is liberated from stimulated neutrophils and macrophages, and catecholamines, which are present in the circulation and show high levels after stress and cigarette smoking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Siess W. Molecular mechanisms of platelet activation. Physiol. Rev. 69:58–178 (1989).
Siess, W., Lapetina, E.G. Calcium primes protein kinase C in human platelets. Biochem. J. 255:309–318 (1988).
Siess W., Lapetina E.G. Platelet aggregation induced by α2-adrenoceptor- and protein kinase C activation: A novel synergism. Biochem. J. in press (1989).
Olbrich C., Siess W. Epinephrine and the Ca2+-ionophore A 23187 synergistically induce platelet aggregation without protein kinase C activation. FEBS Lett. 243:275–279 (1989).
Friedman J., Stemerman M.D., Wenz B., Moore S., Gauldie J., Gent M., Tiell M.L., Spaet T.H. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. J. Clin. Invest. 60:1191–1201 (1977).
Schwartz C.J., Valente A.J., Kelley J.L., Sprague E.A., Edwards E.H. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin. Thrombos. Hemostas. 14:189–195 (1988).
Ross R. The pathogenesis of atherosclerosis — an update. N. Engl. J. Med. 314:488–500 (1986).
Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376 (1980).
Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium- derived relaxing factor. Nature 327:524–526 (1987).
Freiman P.C., Mitchell G.C., Heistad D.D., Armstrong M.L., Harrison D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res. 58:783–789 (1986).
Radomski M.W., Palmer R.M.J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057–1058 (1987).
Moncada S., Gryglewski R., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoper-oxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665 (1976).
Radomski M.W., Palmer R.M.J., Moncada S. The antiaggregating properties of vascular endothelium: interaction between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:639–646 (1987).
Brook G.J., Aviram M. Platelet lipoprotein interactions. Semin. Thrombos. Hemostas. 14:258–265 (1988).
Shattil S.J., Anaya-Galindo R., Bennett J., Colman R.W., Cooper R.A. Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55:636–643 (1975).
Koller E., Koller F., Binder B.R. Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. J. Biol. Chem. 264:12412–12418 (1989).
Andrews H.E., Aitken J.W., Hassal D.G., Skinner V.O., Bruckdorfer K.R. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem. J. 242:559–564 (1987).
Block L.H., Knorr M., Vogt E., Locher R., Vetter W., Grosgurth P., Qiao B-Y., Pometta D., James R., Regenass M., Pletscher A. Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc. Natl. Acad. Sci. 85:885–889 (1988).
Faggiotto A., Ross R., Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323- (1984).
Munro M.J., Cotran R. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58:249–261 (1988).
Sevitt S. Platelets and foam cells in the evolution of atherosclerosis. Atherosclerosis 61:107–115 (1986).
Curtiss L.K., Black A.S., Takagi Y., Plow E.F. New mechanisms for foam cell generation in atherosclerosis lesions. J. Clin. Invest. 80:367–373 (1987).
Mendelsohn M.E., Loscalzo J. Role of platelets in cholesterol ester formation by U-937 cells. J. Clin. Invest, 81:62–68 (1988).
Larsen E., Celi A., Gilbert G.E., Furie B.C., Erban J.K., Bonfanti R., Wagner D.D., Furie B. PADGEM Protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305–312 (1989).
Sandberg H., Anderson L-O, Hoglund S. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets. Biochem. J. 203:303–311 (1982).
Kruth H.S. Platelet mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 227:1243–1245 (1985).
Kaplan K.L. Platelet granule proteins: localization and secretion. In Platelets in Biology and Pathology-2, J.L. Gordon (ed) Elsevier, Amsterdam p. 80–90 (1981).
Ross R. Platelet derived growth factor. Lancet 1:1179–1182 (1989).
Usuki K., Heldin N-E., Miyazono K., Ishikawa F., Takaku F., Westermark B., Heldin C-H. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. Proc. Natl. Acad. Sci. USA 86:7427–7431 (1989).
Dyerberg J., Bang H.O. Hemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2:433–435 (1979).
Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. Eicosapentaenoic acid and prevention of thombosis and atherosclerosis. Lancet 2:117–119 (1978).
Siess W., Scherer B., Bohlig B., Roth P., Kurzmann I., Weber P.C. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1:441–444 (1980).
Leaf A., Weber P.C. Cardiovascular effects of n-3 fatty acids. N. Engl. J. Med. 318:549–557 (318).
Kromhout D., Bosschieter E.B., Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312:1205–1216 (1985).
Burr M.L., Gilbert J.F., Holiday R.M., Elwood P.C., Fehily A.M., Rogers S. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:758–761 (1989).
Weiner B.H., Ockene I.S., Levine P.H., Guenoud H., Fisher M., Johnson B.F. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N. Engl. J. Med. 315-841-846 (1986).
Davis H.R., Bridenstine R.T., Vesselinovitch D., Wissler R.W. Fish oil inhibits development of atherosclerosis in Rhesus monkeys. Arteriosclerosis 7:441–449 (1987).
Turpie A.G.G. Clinical studies: Evidence for intervention with specific antiplatelet drugs in arterial thromboembolism. Semin. Thromb. Hemostas. 14:4–49 (1988).
ISIS-2 collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet II: 349 (1988).
The steering committee of the physicians health study research group. Preliminary report: findings from the aspirin component of the ongoing physicians health study. N. Engl. J. Med. 318:262-(1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Siess, W. (1990). Platelets in the Pathogenesis of Atherosclerosis. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5829-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5831-2
Online ISBN: 978-1-4684-5829-9
eBook Packages: Springer Book Archive